01
Provenance
Every line names its manufacturer. Toei Shinyaku for the KA21 supplements, MedVigilance for the rings. If we cannot name who made it, we do not carry it.
YokohamaDubaiKabulAbbotsford
Quality that travels.
Nexara Pharma moves diagnostic systems, medical devices and Japanese supplements along a corridor that runs from Yokohama to Kabul — and is building the manufacturing capacity to close it.
0
Offices across
four regions
four regions
0
Product
categories
categories
0
Lines in the
catalogue
catalogue
2030
GMP complex
target
target
↔ Drag to rotate · click a marker
01 Where to start
One corridor,
three ways in.
Company
Trading today, manufacturing tomorrow
Who runs it, where the eight offices are, and the five-year plan behind a USD 30 million manufacturing complex in Afghanistan.
Read the planTechnology
Smart rings and point-of-care devices
Turn the FyRing in 3D, and open any of eight diagnostic device families for sample type, format and supply terms.
See the hardwarePortfolio
The King Agaricus KA21 line
Japan's Toei Shinyaku, one cultivated strain, eight products — from sachets to bulk raw material. Full 360° detail on every line.
Open the catalogue02 Global reach
Own offices in eight
countries. Not agents.
Canada, Japan, the UAE, Afghanistan, India, China, Pakistan and Uzbekistan — staffed by Nexara, not resold through a middleman.
Chapter 01
The company
A trading and distribution house today, capitalising a domestic manufacturing complex for tomorrow — run from eight offices across four regions.
01 Mandate
Two engines,
one direction.
Nexara is built as two connected engines: a near-term trading, OEM/ODM and distribution business, and a long-term Afghanistan manufacturing investment. The first builds supplier relationships, market intelligence and regulatory knowledge; the second follows once that foundation — and verified demand — is in place. Everything in the catalogue is sourced against the registration in force in the destination market and delivered through offices Nexara staffs itself.
Pillar 1 — Trading today
OEM, private label & distribution
Global sourcing of medical devices, diagnostics, smart ring technology and Japanese supplements, moved under private-label, OEM and ODM terms into Central Asia, South Asia, the Gulf and North America.
Pillar 2 — Manufacturing tomorrow
The Afghanistan complex
An integrated, GMP-oriented manufacturing complex with a target budget of USD 30 million — a separate, asset-backed investment stream that draws on the market intelligence the trading business builds first.
02 The five-year roadmap
Trade first.
Manufacture once it's proven.
The plan moves step by step: build distribution strength, then invest in production. Years marked in green are behind us.
2019
AID Group established
The industrial base — agriculture, processing, logistics and lab services — that Nexara is built on.
CompleteYear 1 · 2023
Build & establish
Canadian office opens in Abbotsford. Supplier qualification, initial products, core distribution, and regulatory mapping begin.
CompleteYear 2 · 2024
Expand & strengthen
Supply agreements signed with Toei Shinyaku for the KA21 line and MedVigilance for smart ring technology. Private-label channels open across the Gulf and Afghanistan.
CompleteYear 3 · 2025 – 2026
Scale & prepare
Eight offices now live across Canada, Japan, the UAE, Afghanistan, India, China, Pakistan and Uzbekistan. Broader OEM/ODM portfolio, manufacturing demand data, and site and design decisions underway.
In progressYear 4 · 2027 – 2028
Build & commission the facility
Construction of a cleanroom-controlled complex: a tablet and capsule block, a liquid and syrup block, a separately contained specialised block, and a QC and microbiology lab. Equipment installation, staff recruitment and validation.
PlannedYear 5 · 2029 – 2030
Operate & export
Commercial production ramp-up, OEM manufacturing for partners, and the quality certification pathway that makes export possible.
Target
Reference facility · indicative of the planned complex
✓USD 30M target budgetGMP-oriented
✓Four production blocksPlanned
03 Leadership
Built by someone
who knows the region.
Founder of Nexara Pharma and Founder and Chief Executive of AID Group. Born in Koobi village, Kandahar province. Three decades building industry in a region most companies only ship to.
- EducationBSc Medical Science · BBA Business Administration · MSc Industrial Management
- GovernmentSenior Advisor to the President of Afghanistan on Domestic Production and Export
- CouncilMember, High Economic Council of Afghanistan — seven years
- ConsularHonorary Consul General of Kazakhstan in Kandahar — two years
- ChamberChairman, Afghanistan–German Business Chamber
- BoardsICC Afghanistan · Afghanistan Mines & Industry Chamber of Commerce
- MemberAfghan-American Chamber · Afghanistan–Canada Business Council
AID GroupKanda Fruits ProcessKanda Agro Services
Kanda CarpetKanda Food Supply UAEWazirzai Global Lab Services
Kanda DigitalKanda Med PharmaJalal Kabab House
04 Careers
Building across
eight time zones.
Nexara hires locally in every office rather than running the network from one country. There is no fixed list of open roles here — the network is small and roles open as the business needs them.
Regulatory & registration
Ongoing, across officesDistribution & sales
Ongoing, across officesSomething else
We read every messageChapter 02
The network
Eight offices, four regions — staffed by Nexara, not resold through agents.
01 Offices
Eight offices.
Our own people.
These are offices we staff, not agents we have never met. Every card below carries the real address and number.
02 Assurance
What a partner
checks first.
Before anyone talks about price, they ask who made it, whether it is registered here, and what happens when a batch is questioned. Those answers come before the catalogue.
✓Named manufacturersNo blind sourcing
✓Certificate of analysisPer batch, on request
✓Market registrationConfirmed before shipment
✓Own officesEight countries, our staff
✓Cold-chain capableWhere the product requires it
02
Documentation
Specification sheets, certificates of analysis, stability data and manufacturer statements are supplied with the quotation, not after the order.
03
Registration
Approved indications and device class differ by jurisdiction. We confirm status in the destination market before committing to a delivery date.
04
Labelling
Artwork, language and permitted claims are adjusted per market. Nothing ships carrying a claim that market has not approved.
Step 01
Enquiry
You tell us the market, the volume and the intended channel.
Step 02
Registration check
We confirm what is approved where you are selling, and what is not.
Step 03
Documentation
Specification, certificate of analysis and manufacturer statements issued.
Step 04
Sample and artwork
Samples shipped, labelling adapted to the destination market.
Step 05
Supply
Order confirmed against agreed terms, shipped from the nearest office.
Chapter 03
The technology
Two wearables from MedVigilance in Yokohama, and eight point-of-care device families — every one turnable in your hands before you order a sample.
01 Wearables
Sensing that
stays on the hand.
Drag the ring above to turn it, or use the stage below. Switch models and colourways here.
Drag to rotate
FyRing 2
Titanium body, continuous optical sensing, IP68 water resistance and Bluetooth Low Energy 5.0.
02 Diagnostics
Point-of-care testing,
under your brand or ours.
Eight device families supplied on private-label, OEM and ODM terms. Open any family for sample type, format and supply terms.
Blood glucose
Meters, strips and lancing systems for diabetes management.
Multi-function analysers
Combined platforms measuring several markers from one sample.
Uric acid
Rapid quantitative testing for gout and metabolic screening.
Lipid panel
Total cholesterol, HDL, LDL and triglycerides at the point of care.
Hemoglobin
Anaemia screening for clinics, blood drives and field programmes.
Urine analysis
Multi-parameter strips and readers for routine urinalysis.
Fertility
Ovulation and pregnancy rapid tests in cassette, strip and midstream.
Infectious disease
Rapid antigen and antibody tests across a range of pathogens.
Device availability and approved indications vary by jurisdiction. Registration
status is confirmed per market before any commitment is made.
Chapter 04
The portfolio
The King Agaricus KA21 line, made in Japan by Toei Shinyaku from a single cultivated strain. Open any line — drag it in 360° and read the full specification.
01 Catalogue
The King Agaricus
KA21 line.
Manufactured by Toei Shinyaku Co., Ltd. in Japan from a single cultivated Agaricus blazei strain, KA21. Working from one strain is what lets a single specification hold across the whole range. Open any line for full detail.
KA21
King Agaricus 100 — Sachets
Liquid extract in single-serve sachets. The flagship presentation of the line.
KA21
King Agaricus 100 — Tablets
The same extract in tablet form, for markets that prefer a solid dose.
KA21
BEROOT KA21
KA21 combined with beetroot extract, in the manufacturer's everyday range.
KA21
NKUP for Men KA21
A men's formulation built on the KA21 base extract.
KA21
Cleansia KA21
A daily formulation from the same manufacturer and the same base.
Veterinary
King Agaricus 100 for Pets
A veterinary presentation of the KA21 extract for companion animals.
B2B
KA21 Raw Material
Bulk extract for formulators and contract manufacturers, with documentation.
Source
The KA21 strain
Cultivated in Japan under controlled conditions, with decades of published work.
Product claims and permitted indications differ by market. All labelling and
claims are adjusted to the regulatory approval in force in each destination country before shipment.
Chapter 05
Insights
Notes on regulation, sourcing and supply for people who buy and register pharmaceuticals for a living — plus the questions we get before the first order.
01 Insights
Notes from
the corridor.
Short pieces on regulation, sourcing and supply into Central and South Asia. Written for people who buy and register pharmaceuticals for a living.
Regulation
Why registration status decides your delivery date
The gap between "available" and "importable" is where most first-time pharmaceutical orders fail. A short guide to checking approval before you commit to a customer.
Sourcing
Reading a certificate of analysis properly
What each section of a CoA actually tells you, which fields matter for a customs officer, and the three checks worth doing before a batch leaves the manufacturer.
Diagnostics
Point-of-care testing where the lab is far away
Why rapid diagnostics change clinical practice more in rural Central Asia than they do in well-served cities, and what that means for the devices you should stock.
02 Frequently asked
Questions we get
before the first order.
Do you sell direct to consumers?
No. Nexara operates business to business — distributors, clinics, pharmacies and manufacturers. Consumer enquiries are pointed to a registered distributor in their market where one exists.
Can you ship into a country not on the office list?
Sometimes, through one of the eight offices rather than directly. Tell us the destination in the enquiry form and we will confirm whether it is workable before quoting.
What documentation comes with an order?
Specification sheet, certificate of analysis and manufacturer statements as standard. For devices, instructions for use and performance data as well. All issued with the quotation, not after payment.
Are your supplements approved as medicines?
The King Agaricus KA21 line is sold as a food supplement, not a medicine, and labelled accordingly in every market. Permitted wording differs by country and is set against local approval before shipment.
How long does a first order take?
It depends on the registration check in your market, not on stock. Some markets move in days, others need weeks of paperwork before the first shipment can move at all. We tell you which situation you're in before you commit.
Can I visit an office before ordering?
Yes, at any of the eight. Mention it in your enquiry and we will arrange a time with the local team.
Chapter 06
Get in touch
Three ways in, a direct line to Canada and Japan, and a client area for registered partners.
01 Engage
Three ways in.
Emailinfo@nexaralifecare.com
Canada+1 604 217 1225
Japan+81 45 550 7200
Head officeAbbotsford, British Columbia
Client area
Registered partners can sign in for documentation, price lists and order history.
Accounts are issued by Nexara, not self-registered. Ask your account contact to create one for you.